Sfoglia per AUTORE
MANISCALCO GT
Collezione AOU San Luigi di Orbassano

  

Items : 22

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study. in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7.
2024
AOU San Luigi di Orbassano

Chisari CG; Aguglia U; Amato MP; Bergamaschi R; Bertolotto A; Bonavita S; Morra VB; Cavalla P; Cocco E; Conte A; Cottone S; De Luca G; Di Sapio A; Filippi M; Gallo A; Gasperini C; Granella F; Lus G; Maimone D; Maniscalco GT; Marfia G; Moiola L; Paolicelli D; Pesci I; Ragonese P; Rovaris M; Salemi G; Solaro C; Totaro R; et alii...

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. in Journal of neurology / J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Solaro C; Cocco E; Moccia M; Tomassini V; Lanzillo R; Malucchi S; Paolicelli D; De Luca G; Laroni A; Calabrese M; Gajofatto A; Buttari F; Guaschino C; Radaelli M; Fantozzi R; Clerico M; Di Sabatino E; Cavalla P; Nociti V; Lorefice L; Gallo A; Prosperini L; Maniscalco GT; Ragonese P; Ferraro D; Di Filippo M; Gasperini C;

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

A real-world study of alemtuzumab in a cohort of Italian patients. in European journal of neurology / Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5.
2022
AOU San Luigi di Orbassano

Russo CV; Saccà F; Frau J; Annovazzi P; Signoriello E; Bonavita S; Grasso R; Clerico M; Cordioli C; Laroni A; Capobianco M; Torri Clerici V; Sartori A; Cavalla P; Maniscalco GT; La Gioia S; Caleri F; Giugno A; Iodice R; Carotenuto A; Cocco E; Fenu G; Zaffaroni M; Baroncini D; Lus G; Gallo A; De Mercanti SF; Lapucci C; Di Francescantonio V; et alii...

2022
ASL Cuneo 1
AOU San Luigi di Orbassano

Bellantonio P; Totaro R; Vianello M; Cavalla P; Granella F; Di Sapio A; Bertolotto A; Maimone D; Bergamaschi R; Lus G; Solaro C; Amato MP; Rovaris M; Gasperini C; Ferrò MT; Pesci I; Aguglia U; Maniscalco GT; Sola P; Conte A; De Luca G; Cottone S; Salemi G; Lugaresi A; Inglese M; Bonavita S; Grimaldi LM; Marfia GA; Brescia Morra V; et alii...

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Cocco E; Gasperini C; Solaro C; Gazzola P; Gallo A; Maniscalco GT; Paolicelli D; Calabrese M; Borrelli A; Tomassini V; De Luca G; Clerico M; Boffa L; Lanzillo R; Moccia M; Ferraro D; Gajofatto A; Prosperini L; Fantozzi R; Buttari F; Laroni A; Lorefice L; Radaelli M; Nociti V; Torri Clerici V; Cavalla P; Annovazzi P; Malucchi S; et alii...

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study. in Journal of the neurological sciences / J Neurol Sci. 2021 May 15;424:117385. doi: 10.1016/j.jns.2021.117385. Epub 2021 Mar 6.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Frangiamore R; Laroni A; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Cocco E; Lorefice L; Maniscalco GT; Curti E; Lavorgna L; Abbadessa G; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; De Mercanti SF; Cavalla P; Costantini G; Capra R; Sormani MP; Clerico M;

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. in Therapeutic advances in neurological disorders / Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollectio
2021
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Caputo F; Paolicelli D; Patti F; Zaffaroni M; Brescia Morra V; Pozzilli C; De Luca G; Inglese M; Salemi G; Maniscalco GT; Cocco E; Sola P; Lus G; Conte A; Amato MP; Granella F; Gasperini C; Bellantonio P; Totaro R; Rovaris M; Salvetti M; Torri Clerici VLA; Bergamaschi R; Maimone D; Scarpini E; Capobianco M; Comi G; et alii...

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):914-920. doi: 10.1136/jnnp-2019-322480. Epub 2020 Jul
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Spinicci G; Spitaleri D; Sessa E; Rovaris M; Righini I; Pontecorvo S; Petrucci L; Matta M; Paolicelli D; Maniscalco GT; Lus G; Lanzillo R; Guareschi A; Gasperini C; Gajofatto A; Esposito F; Danni MC; Cottone S; Centonze D; Costantino G; Castelli L; Cavalla P; Capello E; Bruno Bossio R; Brescia Morra V; Bonavita S; Bianco A; Bergamaschi R; Annunziata P; et alii...

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano

Gobbi C; Uccelli A; Signori A; Amato MP; Granella F; Barilaro A; Abbadessa G; Fenu G; Brescia Morra V; Prestipino E; Sperli F; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Gallo A; Sacco R; Mechi C; Salemi G; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Barone S; Maniscalco GT; Di Sapio A; et alii...

Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Oct;41(10):2905-2913. doi: 10.1007/s10072-020-04413-6. Epub 2020 Apr 25.
2020
AOU San Luigi di Orbassano

Patti F; Chisari CG; Solaro C; Benedetti MD; Berra E; Bianco A; Bruno Bossio R; Buttari F; Castelli L; Cavalla P; Cerqua R; Costantino G; Gasperini C; Guareschi A; Ippolito D; Lanzillo R; Maniscalco GT; Matta M; Paolicelli D; Petrucci L; Pontecorvo S; Righini I; Russo M; Saccà F; Salamone G; Signoriello E; Spinicci G; Spitaleri D; Tavazzi E; et alii...

Cladribine vs other drugs in MS: Merging randomized trial with real-life data. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2020 Aug 14;7(6):e878. doi: 10.1212/NXI.0000000000000878. Print 20
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sormani MP; Visconti A; Landi D; Ippolito D; Esposito S; Russo CV; Barrilà C; Barone S; Grasso R; Pontecorvo S; Di Sapio A; Stromillo ML; Cordioli C; Rasia S; Sartori A; Clerici VT; Fenu G; Cocco E; Frau J; Barcella V; Frigeni B; La Gioia S; Pareja-Gutierrez L; Laroni A; Zarbo IR; Lavorgna L; Bonavita S; Perini P; Mataluni G; et alii...

First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102059. doi: 10.1016/j.msard.2020.102059. Epub 2020 Mar 16.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Signori A; Sormani MP; Carmisciano L; Turano G; Ippolito D; Russo CV; Frigeni B; Landi D; Barrilà C; Barone S; Lavorgna L; Grasso R; Di Sapio A; Cerqua R; Pontecorvo S; Stromillo ML; Cordioli C; Signoriello E; Rasia S; Sartori A; Zarbo IR; Laroni A; Frau J; Cocco E; Torri Clerici V; La Gioia S; Gutierrez LP; Clerico M; Mataluni G; et alii...

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Laroni A; Frangiamore R; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Lorefice L; Cocco E; Curti E; Maniscalco GT; Lavorgna L; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; Iudicello M; De Mercanti SF; Clerico M; Cavalla P; Costantini G; Sormani MP; Capra R;

Informing MS patients on treatment options: a consensus on the process of consent taking. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Aug;41(8):2249-2253. doi: 10.1007/s10072-020-04339-z. Epub 2020 Apr 2.
2020
AOU San Luigi di Orbassano

Tortorella C; Solaro C; Annovazzi P; Boffa L; Buscarinu MC; Buttari F; Calabrese M; Cavalla P; Cocco E; Cordioli C; De Luca G; Di Filippo M; Fantozzi R; Ferraro D; Gajofatto A; Gallo A; Lanzillo R; Laroni A; Fermo SL; Malucchi S; Maniscalco GT; Moccia M; Nociti V; Paolicelli D; Pesci I; Prosperini L; Ragonese P; Tomassini V; Clerici VLAT; et alii...

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study. in Journal of neurology / J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17.
2019
AOU San Luigi di Orbassano

Frau J; Saccà F; Signori A; Baroncini D; Fenu G; Annovazzi P; Capobianco M; Signoriello E; Laroni A; La Gioia S; Sartori A; Maniscalco GT; Bonavita S; Clerico M; Russo CV; Gallo A; Lapucci C; Carotenuto A; Sormani MP; Cocco E;

2019
AOU San Luigi di Orbassano

Paolicelli D; Lucisano G; Manni A; Avolio C; Bonavita S; Brescia Morra V; Capobianco M; Cocco E; Conte A; De Luca G; De Robertis F; Gasperini C; Gatto M; Gazzola P; Lus G; Iaffaldano A; Iaffaldano P; Maimone D; Mallucci G; Maniscalco GT; Marfia GA; Patti F; Pesci I; Pozzilli C; Rovaris M; Salemi G; Salvetti M; Spitaleri D; Totaro R; et alii...

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. in Journal of neurology / J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.
2018
ASL Vercelli
AOU San Luigi di Orbassano

Gajofatto A; Pesci I; Laroni A; Coghe G; Gallo A; Pinardi F; Buscarinu MC; Di Filippo M; Maniscalco GT; Ragonese P; Buttari F; Boffa L; Clerici VT; Malucchi S; Radaelli M; Cavalla P; Annovazzi P; Nociti V; Tortorella C; Fantozzi R; Moccia M; Gasperini C; Prosperini L; Lanzillo R; Calabrese M; Tomassini V; Cocco E; Solaro C;

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study). in PloS one / PLoS One. 2017 Aug 1;12(8):e0180651. doi: 10.1371/journal.pone.0180651. eCollection 2017.
2017
AOU San Luigi di Orbassano

Messina S; Solaro C; Righini I; Bergamaschi R; Bonavita S; Bossio RB; Brescia Morra V; Costantino G; Cavalla P; Centonze D; Comi G; Cottone S; Danni MC; Francia A; Gajofatto A; Gasperini C; Zaffaroni M; Petrucci L; Signoriello E; Maniscalco GT; Spinicci G; Matta M; Mirabella M; Pedà G; Castelli L; Rovaris M; Sessa E; Spitaleri D; Paolicelli D; et alii...

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):944-51. doi: 10.1136/jnnp-2015-312591. Epub 2016 May 9
2016
AOU San Luigi di Orbassano

Patti F; Messina S; Solaro C; Amato MP; Bergamaschi R; Bonavita S; Bruno Bossio R; Brescia Morra V; Costantino GF; Cavalla P; Centonze D; Comi G; Cottone S; Danni M; Francia A; Gajofatto A; Gasperini C; Ghezzi A; Iudice A; Lus G; Maniscalco GT; Marrosu MG; Matta M; Mirabella M; Montanari E; Pozzilli C; Rovaris M; Sessa E; Spitaleri D; et alii...

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon ?-1a using an electronic device: the RIVER study. in Expert opinion on drug delivery / Expert Opin Drug Deliv. 2016 Jul;13(7):931-5. doi: 10.1517/17425247.2016.1148029. Epub 2016 Feb 24.
2016
AOU San Luigi di Orbassano

Lugaresi A; De Robertis F; Clerico M; Brescia Morra V; Centonze D; Borghesan S; Maniscalco GT;